Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Directional interfacial charge transfer in NiFe heterostructure nanozymes for ultrasensitive cancer diagnostics.

Created on 10 Nov 2026

Authors

Zhiyi Tan, Fuying Luo, Shibo Huang, Mingzhu Wang, Yanxin Wang, Xiaoping Zhao, Lingjie Meng, Tingan Wang

Published in

Journal of colloid and interface science. Volume 730. Pages 141901. Nov 05, 2026. Epub Nov 05, 2026.

Abstract

Translating the extraordinary intrinsic catalytic activity of nanozymes into ultra-sensitive, label-free diagnostic signals remains a fundamental challenge, primarily due to the limited macroscopic current perturbations induced by trace biomolecular binding. Herein, we transcend this limitation by establishing a seamless intrinsic connection between a hyperactive heterostructure nanozyme and a spatial "nanoscale gatekeeping" amplification paradigm. Initially, a hierarchical porous carbon-encapsulated NiFe alloy/oxide nanozyme (ZIF-C@NiFe) was engineered. Within this architecture, an interfacial work-function mismatch establishes a robust built-in electric field. As unambiguously revealed by X-ray photoelectron spectroscopy (XPS), this field drives a directional Ni-to-Fe charge redistribution, enriching surface Ni3+ species and radically accelerating Fe2+/Fe3+ cycling. This interfacial electronic modulation generates an exceptionally high baseline current for Fenton-like H2O2 cleavage. To harness this powerful catalytic "engine" for sensing, capture antibodies were strategically immobilized at the bottlenecks of the ZIF-C hierarchical pores. Upon specific recognition of carcinoembryonic antigen (CEA), the bulky immunocomplexes act as physical molecular valves. This severe diffusion-gating effect abruptly cuts off substrate mass transport to the hyperactive internal active network, translating a trace molecular binding event into a massive macroscopic signal drop (negative cascade amplification). Driven by this synergetic mechanism, the integrated immunosensor achieves a phenomenal limit of detection of 0.05 fg/mL and demonstrates robust diagnostic accuracy in clinical breast cancer serum samples (AUC = 0.974). This work systematically bridges interfacial electronic engineering with diffusion-gated signal transduction, offering a transformative design rationale for next-generation clinical diagnostics.

PMID:
43003055
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement